Condition
Sternal Fracture
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Unknown2
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02749968Phase 2Completed
Intercostal Liposomal Bupivacaine for the Management of Blunt Chest Wall Trauma
NCT05040399Not ApplicableUnknownPrimary
Sternal Wound Infection in Patients Undergone Sternal Fixation Using Locking Compression Plates
NCT04092374Not ApplicableUnknownPrimary
Assiut University Heart Hospital
NCT02686099Not ApplicableCompletedPrimary
Sternal Closure With SternaLock 360: First in Man Study
NCT01327287Terminated
Early Aggressive Pain Management is Associated With Improved Outcomes in Blunt Thoracic Trauma
Showing all 5 trials